Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Group B streptococcus exploits vaginal epithelial exfoliation for ascending infection.

Vornhagen J, Armistead B, Santana-Ufret V, Gendrin C, Merillat S, Coleman M, Quach P, Boldenow E, Alishetti V, Leonhard-Melief C, Ngo LY, Whidbey C, Doran KS, Curtis C, Waldorf KMA, Nance E, Rajagopal L.

J Clin Invest. 2018 May 1;128(5):1985-1999. doi: 10.1172/JCI97043. Epub 2018 Apr 9.

2.

Diminished Capsule Exacerbates Virulence, Blood-Brain Barrier Penetration, Intracellular Persistence, and Antibiotic Evasion of Hyperhemolytic Group B Streptococci.

Gendrin C, Merillat S, Vornhagen J, Coleman M, Armistead B, Ngo L, Aggarwal A, Quach P, Berrigan J, Rajagopal L.

J Infect Dis. 2018 Mar 13;217(7):1128-1138. doi: 10.1093/infdis/jix684.

3.

A Nonhemolytic Group B Streptococcus Strain Exhibits Hypervirulence.

Gendrin C, Vornhagen J, Armistead B, Singh P, Whidbey C, Merillat S, Knupp D, Parker R, Rogers LM, Quach P, Iyer LM, Aravind L, Manning SD, Aronoff DM, Rajagopal L.

J Infect Dis. 2018 Mar 5;217(6):983-987. doi: 10.1093/infdis/jix646.

4.

Mast cell chymase decreases the severity of group B Streptococcus infections.

Gendrin C, Shubin NJ, Boldenow E, Merillat S, Clauson M, Power D, Doran KS, Abrink M, Pejler G, Rajagopal L, Piliponsky AM.

J Allergy Clin Immunol. 2018 Jul;142(1):120-129.e6. doi: 10.1016/j.jaci.2017.07.042. Epub 2017 Sep 12.

PMID:
28916188
5.

Group B Streptococcus circumvents neutrophils and neutrophil extracellular traps during amniotic cavity invasion and preterm labor.

Boldenow E, Gendrin C, Ngo L, Bierle C, Vornhagen J, Coleman M, Merillat S, Armistead B, Whidbey C, Alishetti V, Santana-Ufret V, Ogle J, Gough M, Srinouanprachanh S, MacDonald JW, Bammler TK, Bansal A, Liggitt HD, Rajagopal L, Adams Waldorf KM.

Sci Immunol. 2016 Oct;1(4). pii: eaah4576. doi: 10.1126/sciimmunol.aah4576. Epub 2016 Oct 14.

6.

A Hyperhemolytic/Hyperpigmented Group B Streptococcus Strain with a CovR Mutation Isolated from an Adolescent Patient with Sore Throat.

Whidbey C, Burnside K, Martinez RM, Gendrin C, Vornhagen J, Frando A, Harrell MI, McAdams R, Rajagopal L.

Clin Res Infect Dis. 2015;2(2). pii: 1018. Epub 2015 Sep 3.

7.

Mast cell degranulation by a hemolytic lipid toxin decreases GBS colonization and infection.

Gendrin C, Vornhagen J, Ngo L, Whidbey C, Boldenow E, Santana-Ufret V, Clauson M, Burnside K, Galloway DP, Adams Waldorf KM, Piliponsky AM, Rajagopal L.

Sci Adv. 2015 Jul 17;1(6):e1400225.

8.

A streptococcal lipid toxin induces membrane permeabilization and pyroptosis leading to fetal injury.

Whidbey C, Vornhagen J, Gendrin C, Boldenow E, Samson JM, Doering K, Ngo L, Ezekwe EA Jr, Gundlach JH, Elovitz MA, Liggitt D, Duncan JA, Adams Waldorf KM, Rajagopal L.

EMBO Mol Med. 2015 Apr;7(4):488-505. doi: 10.15252/emmm.201404883.

9.

Genome and phylogenetic analyses of Trypanosoma evansi reveal extensive similarity to T. brucei and multiple independent origins for dyskinetoplasty.

Carnes J, Anupama A, Balmer O, Jackson A, Lewis M, Brown R, Cestari I, Desquesnes M, Gendrin C, Hertz-Fowler C, Imamura H, Ivens A, Kořený L, Lai DH, MacLeod A, McDermott SM, Merritt C, Monnerat S, Moon W, Myler P, Phan I, Ramasamy G, Sivam D, Lun ZR, Lukeš J, Stuart K, Schnaufer A.

PLoS Negl Trop Dis. 2015 Jan 8;9(1):e3404. doi: 10.1371/journal.pntd.0003404. eCollection 2015 Jan.

10.

The sensor histidine kinase RgfC affects group B streptococcal virulence factor expression independent of its response regulator RgfA.

Gendrin C, Lembo A, Whidbey C, Burnside K, Berry J, Ngo L, Banerjee A, Xue L, Arrington J, Doran KS, Tao WA, Rajagopal L.

Infect Immun. 2015 Mar;83(3):1078-88. doi: 10.1128/IAI.02738-14. Epub 2015 Jan 5.

11.

2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography demonstrates target inhibition with the potential to predict anti-tumour activity following treatment with the AKT inhibitor AZD5363.

Maynard J, Ricketts SA, Gendrin C, Dudley P, Davies BR.

Mol Imaging Biol. 2013 Aug;15(4):476-85. doi: 10.1007/s11307-013-0613-3.

PMID:
23344784
12.

Structural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosa.

Gendrin C, Contreras-Martel C, Bouillot S, Elsen S, Lemaire D, Skoufias DA, Huber P, Attree I, Dessen A.

PLoS Pathog. 2012;8(4):e1002637. doi: 10.1371/journal.ppat.1002637. Epub 2012 Apr 5.

13.

Monitoring tumor motion by real time 2D/3D registration during radiotherapy.

Gendrin C, Furtado H, Weber C, Bloch C, Figl M, Pawiro SA, Bergmann H, Stock M, Fichtinger G, Georg D, Birkfellner W.

Radiother Oncol. 2012 Feb;102(2):274-80. doi: 10.1016/j.radonc.2011.07.031. Epub 2011 Aug 30.

14.

High-performance GPU-based rendering for real-time, rigid 2D/3D-image registration and motion prediction in radiation oncology.

Spoerk J, Gendrin C, Weber C, Figl M, Pawiro SA, Furtado H, Fabri D, Bloch C, Bergmann H, Gröller E, Birkfellner W.

Z Med Phys. 2012 Feb;22(1):13-20. doi: 10.1016/j.zemedi.2011.06.002. Epub 2011 Jul 22.

15.

Validation for 2D/3D registration. II: The comparison of intensity- and gradient-based merit functions using a new gold standard data set.

Gendrin C, Markelj P, Pawiro SA, Spoerk J, Bloch C, Weber C, Figl M, Bergmann H, Birkfellner W, Likar B, Pernus F.

Med Phys. 2011 Mar;38(3):1491-502.

16.

Validation for 2D/3D registration. I: A new gold standard data set.

Pawiro SA, Markelj P, Pernus F, Gendrin C, Figl M, Weber C, Kainberger F, Nöbauer-Huhmann I, Bergmeister H, Stock M, Georg D, Bergmann H, Birkfellner W.

Med Phys. 2011 Mar;38(3):1481-90.

17.

Hijacking of the pleiotropic cytokine interferon-γ by the type III secretion system of Yersinia pestis.

Gendrin C, Sarrazin S, Bonnaffé D, Jault JM, Lortat-Jacob H, Dessen A.

PLoS One. 2010 Dec 13;5(12):e15242. doi: 10.1371/journal.pone.0015242.

18.

Efficient implementation of the rank correlation merit function for 2D/3D registration.

Figl M, Bloch C, Gendrin C, Weber C, Pawiro SA, Hummel J, Markelj P, Pernus F, Bergmann H, Birkfellner W.

Phys Med Biol. 2010 Oct 7;55(19):N465-71. doi: 10.1088/0031-9155/55/19/N01. Epub 2010 Sep 16.

19.

Post-translational membrane sorting of the Toxoplasma gondii GRA6 protein into the parasite-containing vacuole is driven by its N-terminal domain.

Gendrin C, Bittame A, Mercier C, Cesbron-Delauw MF.

Int J Parasitol. 2010 Sep;40(11):1325-34. doi: 10.1016/j.ijpara.2010.03.014. Epub 2010 Apr 24.

PMID:
20420842
20.

Stochastic rank correlation: a robust merit function for 2D/3D registration of image data obtained at different energies.

Birkfellner W, Stock M, Figl M, Gendrin C, Hummel J, Dong S, Kettenbach J, Georg D, Bergmann H.

Med Phys. 2009 Aug;36(8):3420-8.

21.

Pharmaceutical applications of vibrational chemical imaging and chemometrics: a review.

Gendrin C, Roggo Y, Collet C.

J Pharm Biomed Anal. 2008 Nov 4;48(3):533-53. doi: 10.1016/j.jpba.2008.08.014. Epub 2008 Aug 22. Review.

PMID:
18819769
22.

Toxoplasma gondii uses unusual sorting mechanisms to deliver transmembrane proteins into the host-cell vacuole.

Gendrin C, Mercier C, Braun L, Musset K, Dubremetz JF, Cesbron-Delauw MF.

Traffic. 2008 Sep;9(10):1665-80. doi: 10.1111/j.1600-0854.2008.00793.x. Epub 2008 Jul 9.

23.

Apicomplexa in mammalian cells: trafficking to the parasitophorous vacuole.

Cesbron-Delauw MF, Gendrin C, Travier L, Ruffiot P, Mercier C.

Traffic. 2008 May;9(5):657-64. doi: 10.1111/j.1600-0854.2008.00728.x. Epub 2008 Feb 24. Review.

24.

Content uniformity of pharmaceutical solid dosage forms by near infrared hyperspectral imaging: A feasibility study.

Gendrin C, Roggo Y, Collet C.

Talanta. 2007 Oct 15;73(4):733-41. doi: 10.1016/j.talanta.2007.04.054. Epub 2007 May 10.

PMID:
19073095
25.

Monitoring galenical process development by near infrared chemical imaging: one case study.

Gendrin C, Roggo Y, Spiegel C, Collet C.

Eur J Pharm Biopharm. 2008 Mar;68(3):828-37. Epub 2007 Aug 10.

PMID:
17881196

Supplemental Content

Loading ...
Support Center